跳至主要内容
临床试验/CTRI/2026/02/104119
CTRI/2026/02/104119尚未招募2 期

Randomized Comparative Clinical Study To Evaluate The Effect Of Classical Preparation Of Upanaha Sweda And Upanaha Patch Using Swedopaga Gana In The Management Of Janusandhigata Vata W.S.R. To Osteoarthritis Of Knee Joint.

Dr Gursimranjeet Singh1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This is a randomized, open-label, two-arm comparative clinical trial evaluating the efficacy of classical Upanaha Sweda versus a novel Upanaha Patch, both prepared using Swedopaga Gana herbs as per Charaka Samhita in managing Janusandhigata Vata with reference to Osteoarthritis of Knee Joint. Sixty participants aged 18-60 years with mild to moderate symptoms will be recruited from the OPD/IPD of Parul Institute of Ayurved and Research, Vadodara and randomized into two groups of 30 each. Group A receives classical Upanaha Sweda (herbal paste applied warm, covered with Eranda Patra, bandaged for 12 hours daily) for 7 days, while Group B receives the ready to use Upanaha Patch (standardized transdermal formulation with the same herbs, heated over steam and applied for 12 hours daily) for 7 days. Both include prior local Abhyanga with Moorchita Tila Taila. Assessments occur at baseline (Day 0), mid-treatment (Day 4), post-treatment (Day 8) and follow-up (Day 14), measuring primary outcomes of pain and stiffness reduction via VAS and KOOS scores and secondary outcomes including range of motion (goniometer), patient satisfaction, compliance, ease of application and adverse effects. The study aims to determine if the innovative patch offers comparable therapeutic benefits with improved practicality, patient comfort and standardization over the classical method. This ready to use Upanaha Patch also have IPR values in regards to the method of preparation with swedopaga gana dravyas.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient fulfilling the signs and symptoms of Janusandhigata Vata of mild grade.
  • 2.Patient of all socio-economic group.
  • 3.Patient who is willing to give written consent.

排除标准

  • 1.Patient having severe systemic illnesses like uncontrolled Hypertension, Diabetes Mellitus.
  • 2.Patient having other joint diseases like Psoriatic Arthritis, Gout Arthritis and Rheumatoid Arthritis.
  • 3.Patient with Pregnancy and lactation.

研究者

发起方
Dr Gursimranjeet Singh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Gursimranjeet Singh

Parul Institute of Ayurved and Research

研究点 (1)

Loading locations...

相似试验